Michael Okonkwo

Michael Okonkwo

IPO & Growth Analyst

Michael Okonkwo is an IPO and growth equity analyst at StockTi. He holds an MBA from Wharton and previously worked in venture capital, giving him a unique perspective on pre-IPO valuations and public market debuts. Michael covers new listings, SPAC transactions, and high-growth companies across all sectors. His analysis focuses on identifying inflection points in emerging companies transitioning from private to public markets.

IPO, Growth Stocks 181 articles

Articles by Michael Okonkwo

Sivers Semiconductors Faces Tight Timeline for Nasdaq Listing and Share Vote
IPO

Sivers Semiconductors Faces Tight Timeline for Nasdaq Listing and Share Vote

Sivers Semiconductors faces a May 11 vote on a 125 million crown share issue and a delayed annual report as it pursues a Nasdaq New York dual listing.

Pershing Square IPO Package Returns to Profit After Volatile Start
IPO

Pershing Square IPO Package Returns to Profit After Volatile Start

Pershing Square Inc. shares rose to $37.99, lifting the combined IPO package above the $50 offer price after a volatile NYSE debut.

UTime Seeks to Withdraw Resale Registration, Shares Surge
IPO

UTime Seeks to Withdraw Resale Registration, Shares Surge

UTime Limited (WTO) shares rose 8.36% after the company asked the SEC to withdraw a resale registration statement that was never declared effective.

WTO
Rare Earths Americas IPO Targets $368M Valuation Amid China Supply Concerns
IPO

Rare Earths Americas IPO Targets $368M Valuation Amid China Supply Concerns

Rare Earths Americas began its U.S. IPO roadshow, aiming for a valuation up to $368.4 million and planning to raise as much as $52.8 million by selling shares at $17–$19 each.

FXI
Brazil's IPO Market Eyes Revival with Cosan's $5.1B Compass Listing
IPO

Brazil's IPO Market Eyes Revival with Cosan's $5.1B Compass Listing

Cosan SA is moving forward with a secondary offering of Compass Gás e Energia shares, targeting up to R$5.1 billion to reduce debt, potentially reviving Brazil's IPO market.

Oruka Therapeutics Soars on Psoriasis Drug Data, Announces $500M Offering
IPO

Oruka Therapeutics Soars on Psoriasis Drug Data, Announces $500M Offering

Oruka Therapeutics shares surged after interim data showed its psoriasis drug ORKA-001 achieved 63.5% complete skin clearance. The company also announced a $500M public offering.

ORKA ABBV UCB
Sagimet Biosciences Soars After $175M Stock Sale to Fund Acne Drug Trial
IPO

Sagimet Biosciences Soars After $175M Stock Sale to Fund Acne Drug Trial

Sagimet Biosciences shares surged 38% after announcing a $175 million stock offering to fund a Phase 3 acne trial for denifanstat, with proceeds expected to support dermatology programs through 2028.

SGMT
Rocket Lab Shares Dip as SpaceX IPO Buzz and Earnings Loom
IPO

Rocket Lab Shares Dip as SpaceX IPO Buzz and Earnings Loom

Rocket Lab shares slipped 2.3% as investors await Q1 earnings due May 7, with SpaceX's IPO intensifying scrutiny of space-sector valuations.

RKLB
SpaceX IPO: Starlink and Starship at Forefront as $1.75 Trillion Valuation Looms
IPO

SpaceX IPO: Starlink and Starship at Forefront as $1.75 Trillion Valuation Looms

SpaceX's confidential IPO filing targets a $1.75 trillion valuation, with Starlink's cash generation and Starship's advancements key to investor appeal.

AMZN MSFT GOOGL
Horizon Quantum Faces Supply Test After 53M-Share Resale Filing
IPO

Horizon Quantum Faces Supply Test After 53M-Share Resale Filing

Horizon Quantum Holdings filed to register the resale of nearly 53 million shares, representing 91.9% of outstanding stock, just weeks after its Nasdaq debut.

IONQ
Xanadu Stock Surges 7% on 294M Share Resale Filing
IPO

Xanadu Stock Surges 7% on 294M Share Resale Filing

Xanadu Quantum Technologies shares climbed 7.28% to $30.95 following a registration statement for up to 293.7 million Class B shares. The filing does not represent new capital for the company.

IONQ RGTI QUBT
Sivers Semiconductors Delays Annual Report Amid Nasdaq NY Listing Review
IPO

Sivers Semiconductors Delays Annual Report Amid Nasdaq NY Listing Review

Sivers Semiconductors (SIVS) pushes its 2025 annual report to May 15 due to audit work for a possible Nasdaq NY dual listing; shares closed up 12.7% on Friday.